Sanofi axes IGM pact, sparking 80% layoffs at the biotech and facility closures

Sanofi, IGM Biosciences, collaboration termination, biotech layoffs, facility closures, IgM antibodies, immunology, inflammation, oncology

WuXi Biologics Divests Irish Vaccine Facility to Merck for $500 Million Amid Strategic Shift

WuXi Biologics, Merck, vaccine manufacturing facility, Dundalk, Ireland, asset sale, strategic shift, regulatory changes, Biosecure Act